最近,鲁抗医药注射用盐酸大观霉素在东南亚某国注册成功,获得了该国颁发的注册证书,这是鲁抗医药建业41年来获得的首个制剂产品国外注册文号,填补了该公司制剂产品出口的空白。注射用大观霉素是鲁抗医药的拳头产品之一,产品质量过硬,在国外市场上有着很强的市场竞争 Recently, Lukang pharmaceutical injection of spectinomycin hydrochloride registered success in a country in Southeast Asia, access to the country issued a certificate of registration, which is Lu Kang Jianye 41 years to obtain the first foreign product registration number, to fill the company Preparation of product export blank. Spectinomycin for injection is one of the leading products of Lukang Pharmaceutical Co., Ltd. The products are excellent in quality and have strong market competition in foreign markets